col blocks we are bridge builder col blocks
COVID answers in Scientific Journals all over the world

BMJ: Journal of Neurology Neurosurgery & Psychiatry
  original article Date Title Authors   All Authors
1 [GO] 2022―Jan―25 Acute ischaemic stroke associated with SARS-CoV-2 infection in North America Adam A Dmytriw, Mahmoud Dibas, Kevin Phan, Aslan Efendizade, Ospel Johanna, Clemens Schirmer, et al. (+62)
2 [GO] 2021―Sep―29 Clinical and biological features of cerebral venous sinus thrombosis following ChAdOx1 nCov-19 vaccination Christina Crossette-Thambiah, Charis Pericleous, Namir Asmar, Joshua Bomsztyk, Amita Ranger, Abdul Shlebak, et al. (+4)
3 [GO] 2021―Sep―28 Anxiety and depression symptoms after COVID-19 infection: results from the COVID Symptom Study app Kerstin Klaser, Ellen J Thompson, Long H Nguyen, Carole H Sudre, Michela Antonelli, Benjamin Murray, et al. (+19)
4 [GO] 2021―Aug―18 Functional disorders after COVID-19 vaccine fuel vaccination hesitancy Alfonso Fasano, Antonio Daniele
5 [GO] 2021―Aug―18 mRNA COVID-19 vaccines do not increase the short-term risk of clinical relapses in multiple sclerosis Massimiliano Di Filippo, Cinzia Cordioli, Simona Malucchi, Pietro Annovazzi, Paola Cavalla, Valentina Torri Clerici, et al. (+26)
6 [GO] 2021―Aug―06 Considerations for causality assessment of neurological and neuropsychiatric complications of SARS-CoV-2 vaccines: from cerebral venous sinus thrombosis to functional neurological disorder Matt Butler, Arina Tamborska, Greta K Wood, Mark Ellul, Rhys H Thomas, Ian Galea, et al. (+6)
7 [GO] 2021―Aug―05 Vaccination and multiple sclerosis in the era of the COVID-19 pandemic Tobias Monschein, Hans-Peter Hartung, Tobias Zrzavy, Michael Barnett, Nina Boxberger, Thomas Berger, et al. (+4)
8 [GO] 2021―Aug―02 Anti-CD20 therapies decrease humoral immune response to SARS-CoV-2 in patients with multiple sclerosis or neuromyelitis optica spectrum disorders Céline Louapre, Michella Ibrahim, Elisabeth Maillart, Basma Abdi, Caroline Papeix, Bruno Stankoff, et al. (+8)
9 [GO] 2021―Jul―16 7 Covid-19 and neuropsychiatry Benedict D Michael
10 [GO] 2021―Jul―16 #3125 Novel framework for neurocognitive COVID-19 assessment Jai Mathur, Alan Carson
11 [GO] 2021―Jul―16 #3123 Assessing international alcohol and internet use patterns during COVID-19 isolation using an online survey: highlighting distinct stressors conferring risk to compulsive behaviours Samantha N Sallie, Valentin JE Ritou, Henrietta Bowden-Jones, Valerie Voon
12 [GO] 2021―Jul―14 Bilateral facial weakness with paraesthesia variant of Guillain-Barré syndrome following Vaxzevria COVID-19 vaccine Guendalina Beatrice Bonifacio, Dharmini Patel, Sarah Cook, Elena Purcaru, Michael Couzins, Janine Domjan, et al. (+8)
13 [GO] 2021―Jun―04 Neurology and neuropsychiatry of COVID-19: a systematic review and meta-analysis of the early literature reveals frequent CNS manifestations and key emerging narratives Jonathan P Rogers, Cameron J Watson, James Badenoch, Benjamin Cross, Matthew Butler, Jia Song, et al. (+24)
14 [GO] 2021―May―26 Ischaemic stroke can follow COVID-19 vaccination but is much more common with COVID-19 infection itself Hugh S Markus
15 [GO] 2021―May―26 Ischaemic stroke as a presenting feature of ChAdOx1 nCoV-19 vaccine-induced immune thrombotic thrombocytopaenia Talal Al-Mayhani, Sadia Saber, Matthew J Stubbs, Nicholas A Losseff, Richard J Perry, Robert J Simister, et al. (+4)
16 [GO] 2021―Apr―27 Neurological diseases and risk of mortality in patients with COVID-19 and SARS: a territory-wide study in Hong Kong Florence Sin Ying Fan, Terry C F Yip, Brian Yiu, Bonnie Lam, Lisa Au, Alexander Yuk-lun Lau, et al. (+7)
17 [GO] 2021―Apr―21 Hypothyroidism is associated with prolonged COVID-19-induced anosmia: a case-control study Georgios Tsivgoulis, Paraskevi C. Fragkou, Emmanouil Karofylakis, Maria Paneta, Konstantinos Papathanasiou, Lina Palaiodimou, et al. (+5)
18 [GO] 2021―Mar―12 Correction: Ischaemic stroke associated with COVID-19 and racial outcome disparity in North America
19 [GO] 2020―Dec―24 Negative impact of COVID-19 lockdown on papilloedema and idiopathic intracranial hypertension Mark Thaller, Georgios Tsermoulas, Rosa Sun, Susan P Mollan, Alexandra J Sinclair
20 [GO] 2020―Nov―20 Pattern of cognitive deficits in severe COVID-19 Valérie Beaud, Sonia Crottaz-Herbette, Vincent Dunet, Julien Vaucher, Raphaël Bernard-Valnet, Renaud Du Pasquier, et al. (+2)
21 [GO] 2020―Nov―06 Epileptiform activity and seizures in patients with COVID-19 Fabiane Santos de Lima, Naoum Issa, Kaitlin Seibert, Jared Davis, Richard Wlodarski, Sara Klein, et al. (+5)
22 [GO] 2020―Nov―06 Characteristics and outcomes of COVID-19-associated stroke: a UK multicentre case-control study Richard J Perry, Craig J Smith, Christine Roffe, Robert J Simister, Saravanan Narayanamoorthi, Richard Marigold, et al. (+14)
23 [GO] 2020―Nov―06 Guillain-Barré syndrome and COVID-19: an observational multicentre study from two Italian hotspot regions Massimiliano Filosto, Stefano Cotti Piccinelli, Stefano Gazzina, Camillo Foresti, Barbara Frigeni, Maria Cristina Servalli, et al. (+39)
24 [GO] 2020―Oct―29 Ischaemic strokes associated with COVID-19: is there a specific pattern? Edouard Januel, Laure Bottin, Marion Yger, Anne Leger, Sophie Crozier, Flore Baronnet, et al. (+10)
25 [GO] 2020―Oct―28 Intravenous thrombolysis for acute ischaemic stroke during COVID-19 pandemic in Wuhan, China: a multicentre, retrospective cohort study Yifan Zhou, Candong Hong, Jiang Chang, Yuanpeng Xia, Huijuan Jin, Yanan Li, et al. (+9)
26 [GO] 2020―Oct―14 COVID-19 impact on consecutive neurological patients admitted to the emergency department Andrea Pilotto, Alberto Benussi, Ilenia Libri, Stefano Masciocchi, Loris Poli, Enrico Premi, et al. (+39)
27 [GO] 2020―Sep―18 Increased ethnicity and socioeconomic data collection required in stroke associated with COVID-19 Danish Hafeez, Jia Song, Cameron Watson, Alasdair Rooney, Timothy R Nicholson
28 [GO] 2020―Aug―28 Antiganglioside antibodies in Guillain-Barré syndrome associated with SARS-CoV-2 infection Carlo Civardi, Alessandra Collini, Dinha Joan Geda, Claudio Geda
29 [GO] 2020―Aug―27 Immunosuppression for intracranial vasculitis associated with SARS-CoV-2: therapeutic implications for COVID-19 cerebrovascular pathology Luke Dixon, Charles Coughlan, Kushan Karunaratne, Nikolaos Gorgoraptis, James Varley, James Husselbee, et al. (+8)
30 [GO] 2020―Aug―27 Self-diagnosed COVID-19 in people with multiple sclerosis: a community-based cohort of the UK MS Register Nikos Evangelou, Afagh Garjani, Roshan dasNair, Rachael Hunter, Katherine A Tuite-Dalton, Elaine M Craig, et al. (+13)
31 [GO] 2020―Aug―27 High mortality rate in COVID-19-associated stroke, analysis of risk factors Leonardo Renieri
32 [GO] 2020―Aug―27 Guillain-Barré syndrome in SARS-CoV-2 infection: an instant systematic review of the first six months of pandemic Antonino Uncini, Jean-Michel Vallat, Bart C Jacobs
33 [GO] 2020―Aug―14 Ischaemic stroke associated with COVID-19 and racial outcome disparity in North America Adam A Dmytriw, Kevin Phan, Clemens Schirmer, Fabio Settecase, Manraj K S Heran, Aslan Efendizade, et al. (+14)
34 [GO] 2020―Jul―30 Guillain-Barré syndrome in times of pandemics Sonja E Leonhard, David R Cornblath, Hubert P Endtz, James J Sejvar, Bart C Jacobs
35 [GO] 2020―Jul―27 Posterior reversible encephalopathy syndrome associated with SARS-CoV-2 infection Abdenour Djellaoui, Lilia Seddik, Laurent Cleret De Langavant, Samuel Cattan, Anne Catherine Bachoud-Lévi, Hassan Hosseini
36 [GO] 2020―Jul―20 Status of SARS-CoV-2 in cerebrospinal fluid of patients with COVID-19 and stroke Fadi Al Saiegh, Ritam Ghosh, Adam Leibold, Michael B Avery, Richard F Schmidt, Thana Theofanis, et al. (+9)
37 [GO] 2020―Jul―20 Psychological impact on women health workers involved in COVID-19 outbreak in Wuhan: a cross-sectional study Guo Li, Jinfeng Miao, Hui Wang, Shabei Xu, Wenzhe Sun, Yebin Fan, et al. (+4)
38 [GO] 2020―Jul―13 A case of limbic encephalitis associated with asymptomatic COVID-19 infection Laura Zambreanu, Sophie Lightbody, Mohit Bhandari, Chandrashekar Hoskote, Hala Kandil, Catherine F Houlihan, Michael P Lunn
39 [GO] 2020―Jul―10 COVID-19-associated acute necrotising encephalopathy successfully treated with steroids and polyvalent immunoglobulin with unusual IgG targeting the cerebral fibre network Louis Delamarre, Cédric Gollion, Gaspard Grouteau, David Rousset, Guillaume Jimena, Jérôme Roustan, et al. (+13)
40 [GO] 2020―Jul―10 Management of patients with generalised myasthenia gravis and COVID-19: four case reports Annemarie Hübers, Agustina M Lascano, Patrice H Lalive
41 [GO] 2020―Jul―07 Postinfectious brainstem encephalitis associated with SARS-CoV-2 Anthony Khoo, Benjamin McLoughlin, Sanjay Cheema, Rimona S Weil, Christian Lambert, Hadi Manji, et al. (+2)
42 [GO] 2020―Jun―23 Nervous system: subclinical target of SARS-CoV-2 infection Sara Mariotto, Alessia Savoldi, Katia Donadello, Serena Zanzoni, Silvia Bozzetti, Sara Carta, et al. (+15)
43 [GO] 2020―Jun―05 Defining causality in COVID-19 and neurological disorders Mark Ellul, Aravinthan Varatharaj, Timothy R Nicholson, Thomas Arthur Pollak, Naomi Thomas, Ava Easton, et al. (+10)
44 [GO] 2020―Apr―30 Characteristics of ischaemic stroke associated with COVID-19 Rahma Beyrouti, Matthew E Adams, Laura Benjamin, Hannah Cohen, Simon F Farmer, Yee Yen Goh, et al. (+9)
45 [GO] 2020―Apr―20 Neurology in the time of covid-19 Hadi Manji, Aisling S Carr, Wallace J Brownlee, Michael P Lunn
46 [GO] 2020―Apr―20 Neurological manifestations of the coronavirus (SARS-CoV-2) pandemic 2019-2020 Kaiming Liu, Mengxiong Pan, Zheman Xiao, Xiaopei Xu


Last change 2022―Jan―26 16:55:12 UTC

© Daten-Quadrat 2022       Done in 0.005 sec